CellCept, Cytoxan Can Significantly Reduce Skin Thickening in Systemic Sclerosis, Study Shows
Long-term treatment with CellCept (mycophenolic acid) or Cytoxan (cyclophosphamide) can significantly reduce skin thickening in patients with systemic sclerosis (SSc), according to study published in the journal Arthritis Care & Research. About 90 percent of SSc patients have thickened skin — a hallmark of this disease. As such, it is commonly used…